Distinct Pharmacodynamic Activity of Rilpivirine in Ectocervical and Colonic Explant Tissue.

about

Future of nonnucleoside reverse transcriptase inhibitors.Frequent cross-resistance to rilpivirine among subtype C HIV-1 from first-line antiretroviral therapy failures in South Africa.

P2860

Q47736959-57BBA87E-512A-4387-BB96-44B3BBCE9817 Q52642470-44AB697C-FA7B-4609-91A3-FAF1446375C2

P2860

Distinct Pharmacodynamic Activity of Rilpivirine in Ectocervical and Colonic Explant Tissue.

Item

http://www.wikidata.org/entity/Q36888077

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Distinct Pharmacodynamic Activ ...... al and Colonic Explant Tissue.

@en

type

Item

label

Distinct Pharmacodynamic Activ ...... al and Colonic Explant Tissue.

@en

prefLabel

Distinct Pharmacodynamic Activ ...... al and Colonic Explant Tissue.

@en

P1476

Distinct Pharmacodynamic Activ ...... al and Colonic Explant Tissue.

@en

P2093

Cory Shetler

http://www.w3.org/2001/XMLSchema#string

David J Back

http://www.w3.org/2001/XMLSchema#string

Ian McGowan

http://www.w3.org/2001/XMLSchema#string

Julie Russo

http://www.w3.org/2001/XMLSchema#string

Laura J Else

http://www.w3.org/2001/XMLSchema#string

Sarah E Yandura

http://www.w3.org/2001/XMLSchema#string

P2860

First phase 1 double-blind, placebo-controlled, randomized rectal microbicide trial using UC781 gel with a novel index of ex vivo efficacy

Preexposure chemoprophylaxis for HIV prevention in men who have sex with men

Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women

Antiretroviral pharmacology in mucosal tissues

Antiretroviral prophylaxis for HIV prevention in heterosexual men and women

In vitro and ex vivo testing of tenofovir shows it is effective as an HIV-1 microbicide

Correlation between compartmental tenofovir concentrations and an ex vivo rectal biopsy model of tissue infectibility in the RMP-02/MTN-006 phase 1 study

Emergence of resistant human immunodeficiency virus type 1 in patients receiving fusion inhibitor (T-20) monotherapy.

Preexposure prophylaxis for HIV infection among African women

Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana

P304

2765-2770

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/AAC.00167-16

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Charlene S Dezzutti

P577

2016-02-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26902757

http://www.w3.org/2001/XMLSchema#string

P932

4862523

http://www.w3.org/2001/XMLSchema#string

Distinct Pharmacodynamic Activity of Rilpivirine in Ectocervical and Colonic Explant Tissue.

about

P2860

P2860

Distinct Pharmacodynamic Activity of Rilpivirine in Ectocervical and Colonic Explant Tissue.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932